Acuitas Investments LLC Acquires 159,743 Shares of Uranium Royalty Corp. $UROY

Acuitas Investments LLC lifted its stake in Uranium Royalty Corp. (NASDAQ:UROY) by 15.8% in the third quarter, Holdings Channel.com reports. The firm owned 1,172,719 shares of the company’s stock after acquiring an additional 159,743 shares during the quarter. Uranium Royalty comprises 3.2% of Acuitas Investments LLC’s portfolio, making the stock its 10th largest holding. Acuitas Investments LLC’s holdings in Uranium Royalty were worth $5,043,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of UROY. Goldman Sachs Group Inc. lifted its holdings in shares of Uranium Royalty by 25.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock valued at $183,000 after buying an additional 21,118 shares during the last quarter. Thompson Davis & CO. Inc. bought a new position in Uranium Royalty in the 2nd quarter worth $33,000. Accordant Advisory Group Inc increased its stake in shares of Uranium Royalty by 4.6% in the second quarter. Accordant Advisory Group Inc now owns 2,441,702 shares of the company’s stock worth $6,104,000 after purchasing an additional 107,216 shares during the period. Vident Advisory LLC lifted its position in shares of Uranium Royalty by 47.1% during the 2nd quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock worth $3,700,000 after purchasing an additional 474,030 shares during the last quarter. Finally, Corient Private Wealth LLC bought a new stake in Uranium Royalty during the 2nd quarter valued at approximately $29,000. 24.19% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Raymond James Financial reaffirmed a “market perform” rating on shares of Uranium Royalty in a research report on Wednesday, January 14th. Weiss Ratings upgraded shares of Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, March 12th. Finally, Zacks Research lowered shares of Uranium Royalty from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 26th. One investment analyst has rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat.com, Uranium Royalty currently has an average rating of “Hold” and a consensus target price of $4.50.

Uranium Royalty Stock Up 1.1%

Shares of Uranium Royalty stock opened at $3.71 on Wednesday. Uranium Royalty Corp. has a twelve month low of $1.43 and a twelve month high of $5.52. The company has a 50-day simple moving average of $4.23 and a two-hundred day simple moving average of $3.98. The stock has a market capitalization of $543.44 million, a price-to-earnings ratio of 185.59 and a beta of 1.46.

Uranium Royalty (NASDAQ:UROY) last issued its quarterly earnings results on Tuesday, March 10th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.02. The business had revenue of $12.25 million during the quarter. Uranium Royalty had a return on equity of 0.01% and a net margin of 7.70%. On average, sell-side analysts anticipate that Uranium Royalty Corp. will post 0.01 earnings per share for the current fiscal year.

About Uranium Royalty

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.